SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

HC Wainwright & Co. Maintains Buy on Meridian Bioscience, Lowers Price Target to $30

HC Wainwright & Co. analyst Yi Chen maintains Meridian Bioscience (NASDAQ:VIVO) with a Buy and lowers the price target from $32 to $30.

05/10/2021 07:16
HC Wainwright & Co. analyst Yi Chen maintains Meridian Bioscience (NASDAQ:VIVO) with a Buy and lowers the price target from $32 to $30.